CVE-2016-8358
The affected software does not verify the identities at communication endpoints, which may allow a man-in-the-middle attacker to gain access to the communication channel between endpoints.
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (0.50%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
An issue was discovered in Smiths-Medical CADD-Solis Medication Safety Software, Version 1.0; 2.0; 3.0; and 3.1. The affected software does not verify the identities at communication endpoints, which may allow a man-in-the-middle attacker to gain access to the communication channel between endpoints.
- CVSS 3.0
- 8.5 HIGHCVSS:3.0/AV:N/AC:H/PR:L/UI:N/S:C/C:H/I:H/A:H
- EPSS
- 0.50% probability · 41th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-346
- Affected
- smiths-medical/cadd-solis medication safety software
- Source
- ics-cert@hq.dhs.gov
References
- http://www.securityfocus.com/bid/94630Third Party Advisory, VDB Entry
- https://ics-cert.us-cert.gov/advisories/ICSMA-16-306-01Third Party Advisory, US Government Resource
- http://www.securityfocus.com/bid/94630Third Party Advisory, VDB Entry
- https://ics-cert.us-cert.gov/advisories/ICSMA-16-306-01Third Party Advisory, US Government Resource
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.